Outcome Comparison Between Percutaneous Vertebroplasty Versus Conservative Treatment in Osteoporotic Vertebral Compression Fracture: A Systematic Review and Meta Analysis

Authors

  • Putu Angga Dharmayuda Orthopedic and Traumatology Department, Prof Ngoerah General Hospital, Faculty of Medicine, Udayana University, Denpasar, Bali Surabaya, Indonesia
  • I Gusti Lanang Ngurah Agung Artha Wiguna Consultant of Orthopedic and Traumatology Department, Prof Ngoerah General Hospital, Faculty of Medicine, Udayana University, Denpasar, Bali Surabaya, Indonesia

DOI:

https://doi.org/10.31282/joti.v7n2.133

Keywords:

percutaneous vertebroplasty, conservative treatment, osteoporotic vertebral compression fracture, meta-analysis

Abstract

Introduction:
Osteoporotic vertebral compression fractures (OVCFs) are common in older adults and cause chronic back discomfort and kyphotic deformity. Percutaneous vertebroplasty (PVP) is preferred over conservative treatment (CT) for pain relief and quality of life improvement. However, there are ongoing debates about PVP's effectiveness and safety, with some suggesting it should only be available to patients who have exhausted other non-invasive options.

Methods:
A systematic review was conducted following the principles outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A thorough literature search was conducted to get a complete, peer-reviewed manuscript in English that compares the outcomes of vertebroplasty versus conservative therapy in osteoporotic compression fractures. We conducted a comprehensive search on PubMed, Google Scholar, and Cochrane Library. This systematic study aims to compare the therapeutic efficacy of vertebroplasty versus conservative therapy.

Results:
The electronic investigation identified 236 entries from various databases, screening them for eligibility, assessing duplicates, and eliminating duplicates, resulting in 9 studies for qualitative and quantitative synthesis. The heterogeneity across studies was examined throughout the I2 statistic described as follows: low, 25% to 50%; moderate 50% to 75%; or high>75%. There is no significant difference found in 1 week and 3 months of pain relief in these two groups in pain relief (mean difference 0.73 (-0.52, 1.96); 95% CI, P = 0,25); (mean difference -0.76 (-2.02, 0.49); 95% CI, =0.23). we found no statistically significant difference between those two groups favoring the PVP group in terms of quality-of-life outcome (mean difference -0.76 (-2.02, 0.49); 95% CI, P < 0.23); (mean difference 1.75 (-0.87, 4.38); 95% CI, P < 0.19). PVP has no association with new adjacent vertebral fractures. (M-H, Fixed, 95% CI
-0.07 (-0.17, 0.03); I2 = 0%, P = 0.16).

Conclusion:
Comparatively, percutaneous vertebroplasty was determined to be more effective in alleviating pain and enhancing quality of life, without posing an elevated risk of nearby vertebral fracture as compared to the CT group. Therefore, it is necessary to conduct a more extensive investigation to determine which patients with osteoporotic vertebral compression fractures (OVCFs) are most likely to experience a positive outcome following percutaneous vertebroplasty (PVP) with little risk of sequelae.

Downloads

Download data is not yet available.

References

Zhao JG, Zeng XT, Wang J, et al. Association between calcium or Vitamin D supplementation and fracture incidence in community-dwelling older adults a systematic review and meta-analysis. JAMA - Journal of the American Medical Association 2017; 318: 2466–2482.

Hinde K, Maingard J, Hirsch JA, et al. Mortality outcomes of vertebral augmentation (vertebroplasty and/or balloon kyphoplasty) for osteoporotic vertebral compression fractures: A systematic review and meta-analysis. Radiology 2020; 295: 96–103.

Edidin AA, Ong KL, Lau E, et al. Morbidity and mortality after vertebral fractures: Comparison of vertebral augmentation and nonoperative management in the medicare population. Spine 2015; 40: 1228–1241.

Anselmetti GC, Corrao G, Monica P della, et al. Pain relief following percutaneous vertebroplasty: Results of a series of 283 consecutive patients treated in a single institution. CardioVascular and Interventional Radiology 2007; 30: 441–447.

Lin H, Bao L hua, Zhu X fen, et al. Analysis of recurrent fracture of a new vertebral body after percutaneous vertebroplasty in patients with osteoporosis. Orthopaedic surgery 2010; 2: 119–123.

Farrokhi MR, Alibai E, Maghami Z. Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures: Clinical article. Journal of Neurosurgery: Spine 2011; 14: 561–569.

Chen D, An ZQ, Song S, et al. Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience 2014; 21: 473–477.

Hansen EJ, Simony A, Rousing R, et al. Double Blind Placebo-controlled Trial of Percutaneous Vertebroplasty (VOPE). Global Spine Journal 2016; 6: s-0036-1582763-s-0036-1582763.

Clark W, Bird P, Gonski P, et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet 2016; 388: 1408–1416.

Firanescu CE, de Vries J, Lodder P, et al. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): Randomised sham controlled clinical trial. BMJ (Online); 361. Epub ahead of print 2018. DOI: 10.1136/bmj.k1551.

Comstock BA, Sitlani CM, Jarvik JG, et al. Investigational Vertebroplasty Safety and Efficacy Trial (INVEST): Patient-reported outcomes through 1 year. Radiology 2013; 269: 224–231.

Klazen CAH, Lohle PNM, de Vries J, et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. www.thelancet.com; 376. Epub ahead of print 2010. DOI: 10.1016/S0140.

Buchbinder R, Osborne RH, Ebeling PR, et al. A Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral Fractures.

Silverman SL. The Clinical Consequences of Vertebral Compression Fracture. 1992.

Chow GH, Nelson BJ, Gebhard JS, et al. 8. Chow. Cast Management of Burst Fracture 1995; 21: 2170–2175.

Mao HQ, Yang HL, Geng DC, et al. Spinal extradural arachnoid cyst following percutaneous vertebroplasty. European Spine Journal; 20. Epub ahead of print 2011. DOI: 10.1007/s00586-010-1569-5.

Belkoff SM, Mathis JM, Jasper LE, et al. The Biomechanics of Vertebroplasty The Effect of Cement Volume on Mechanical Behavior.

Belkoff SM, Mathis JM, Jasper LE, et al. An Ex Vivo Biomechanical Evaluation of a Hydroxyapatite Cement for Use With Vertebroplasty.

Kobayashi K, Shimoyama K, Nakamura K, et al. Percutaneous vertebroplasty immediately relieves pain of osteoporotic vertebral compression fractures and prevents prolonged immobilization of patients. European Radiology 2005; 15: 360–367.

Additional Files

Published

2024-11-08